“ Recombinant Factor VIIa Is Associated With an Improved 24-Hour Survival Without an Improvement in Inpatient Survival in Massively Transfused Civilian Trauma Patients ”. Clinics, vol. 66, no. 1, Jan. 2011, pp. 101-6, https://doi.org/10.1590/S1807-59322011000100018.